TerrAscend (TSNDF) Cash from Operations (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Cash from Operations of 8487000.0 for Q1 2026, down 24.07% year-over-year from 11178000.0 in Q1 2025, and down 58.42% quarter-over-quarter from 20412000.0 in Q4 2025.
TerrAscend (TSNDF) Cash from Operations (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Cash from Operations for 6 consecutive years, with 8487000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations fell 24.07% year-over-year to 8487000.0; the TTM figure through Mar 2026 stood at 31235000.0 (down 29.24% YoY), while the FY2025 annual figure was 33926000.0, down 26.59% from the prior year.
- Cash from Operations eased to 8487000.0 in Q1 2026 per TSNDF's latest filing, from 20412000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 20412000.0 in Q4 2025 and bottomed at 16783000.0 in Q1 2022.
- Historically, Cash from Operations has averaged 5545000.0 across 5 years, with a median of 6792000.0 in 2024.
- Annual changes were most pronounced in 2022 — Cash from Operations sank 370.17% — and 2023, when it surged 626.12%.
- TerrAscend's Cash from Operations stood at 11596000.0 in 2022, then plunged by 50.34% to 5759000.0 in 2023, then advanced by 17.94% to 6792000.0 in 2024, then surged by 200.53% to 20412000.0 in 2025, then sank by 58.42% to 8487000.0 in 2026.
- Business Quant data shows TSNDF's Cash from Operations at 8487000.0 in Q1 2026, 20412000.0 in Q4 2025, and 2693000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TerrAscend | 182.53 Mn | 140.41 Mn | 36.25 Mn | 7.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.39 Mn |
| Jun 30, 2026 | 7.39 Mn |
| Mar 31, 2026 | 8.49 Mn |
| Mar 31, 2026 | 8.49 Mn |
| Dec 31, 2025 | 20.41 Mn |
| Dec 31, 2025 | 20.41 Mn |
| Sep 30, 2025 | 2.69 Mn |
| Sep 30, 2025 | 2.69 Mn |
| Jun 30, 2025 | -357,000.00 |
| Jun 30, 2025 | -357,000.00 |
| Mar 31, 2025 | 11.18 Mn |
| Mar 31, 2025 | 11.18 Mn |
| Dec 31, 2024 | 6.79 Mn |
| Dec 31, 2024 | 6.79 Mn |
| Sep 30, 2024 | 6.11 Mn |
| Sep 30, 2024 | 6.11 Mn |
| Jun 30, 2024 | 20.07 Mn |
| Jun 30, 2024 | 20.07 Mn |
| Mar 31, 2024 | 13.25 Mn |
| Mar 31, 2024 | 13.25 Mn |